Status: Recruiting
The ArtixASCEND Study
This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Inari MedicalUpdated: Jun 2, 2026Locations: 14
Eligibility criteria
Age ≥ 18 years [+6]
Life expectancy < 6 months [+10]